MIND diet and cognitive performance in older adults: a systematic review
Recent evidence showed that Tirzepatide (TZP), a new drug including both Glucagon Like Peptide 1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP) receptor agonism, is effective in subjects with type 2 diabetes (T2D), lowering body weight, fat mass and glycated hemoglobin (HbA 1c ) also in obese or overweight adults without T2D
This is particularly important, as individuals with a history of self-harm or suicidal ideation could be most vulnerable to adverse psychiatric events related to GLP-1 receptor agonist use
Youll likely pay around $600 for each dispensing which can last around a month
Over time, that imbalance can affect how cells function and how the skin and body respond to stress, fatigue, and environmental exposure
Circulation 117 , 27612768 (2008)